Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The text follows the style standards and bibliographic requirements described in Guidelines for Authors , on the About the Journal page.
  • The text is in simple space; uses a 12-point font; uses italic instead of underlining (except URL addresses);
  • Title page as the first page of the paper.
  • All authors have authorized the publication of this article and agree to assign the copyright to the journal.
  • All authors are registered on the journal's website and were included in the submission.
  • If required, submit the approval of the Human Research Ethics Committee.
  • doi for referrals were informed when possible.

Author Guidelines

  1. Scope and ethics in publishing

RBFHSS publishes articles on issues related to hospital pharmacy and other health services. Among these are the management and evaluation of services in the pharmaceutical care assistance, clinical pharmacy and pharmaceutical care, home care, waste management, risk management and patient safety, pharmacotherapy, clinical pharmacogenetics, use of integrative and complementary practices in health services, health technology assessment, innovation in health care, hospital pharmaco-technics, applied legislation, drug stability and compatibility studies, quality control, pharmaco-economics, pharmaco-epidemiology, pharmacovigilance and techno-security.

The studies must follow all the national and international standards for research with human beings or animals and report their approval numbers to the ethics committee, if applicable. In these cases, when approved, attach a copy of the research's approval by the Ethics Committee for Research with Human Beings or by the Ethics Committee on the Use of Animals.

Controlled clinical trials should present documentation regarding the research's registration in a clinical trial database, considering the orientation of the International Clinical Trial Registry Platform (ICTRP) of the World Health Organization (WHO), and of the International Committee of Medical Journal Editors (ICMJE) and Systematic Reviews, PROSPERO.

The authors are responsible for the opinions expressed, which do not necessarily reflect the RBFHSS. The mention of certain companies or commercial products does not imply that they are to be approved or recommended rather than others of a similar nature. The authors should declare potential and actual conflicts of interest regarding the article, when they exist.

  1. Types of articles published

Editorials: concerning a topic of interest or the articles published in the journal; they reflect the author's opinion, an expert in the field, who may be an editorial team member or an independent author invited by the editor, see Table 1.

Original papers: original research reports on topics of interest in the field. Papers presented at meetings and conferences are not necessarily qualified as scientific papers, see Table 1. Original papers should follow the international recommendations for writing and standardization, especially in the Methods section, as recommended by the international guidelines, such as the STROBE Statement (Strengthening the reporting of observational studies in epidemiology), CONSORT (Consolidated Standards of Reporting Trials) and the CHEERS Statement (Consolidated Health Economic Evaluation Reporting Standards). More details can be found on the Equator Network about which quality instrument is suitable for your type of study (http://www.equator-network.org/).

Case reports, experience reports, and evaluation of health services: The communication of cases or of rare or unusual outcomes, with pioneering treatments, is relevant, see Table 1. They must be approved by the Research Ethics Committee as well as have the patient's consent, if applicable. Case studies and evaluations of programs or services may also be submitted for peer review if they involve innovation. Articles related to experience reports, however, besides presenting description and analysis of innovative practices in pharmaceutical assistance, care or education, should only be submitted for evaluation upon invitation of the RBFHSS editorial board.

Narrative and integrative reviews: these types of reviews will only be accepted for peer review if the authors are invited by the editorial board, see Table 1. Alternatively, you may consult the Editor-in-Chief for publication interest (rbfhss@sbrafh.org.br). In this case, include a list of publications indexed on PubMed that demonstrate the authors' experience with the topic.

Other types of review: Systematic reviews with or without meta-analysis should follow the recommendations of the PRISMA Statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and will be considered as original articles, see Table 1.

Perspective Articles: original contributions, which always occur by invitation of the editors, on themes, techniques, and methods relevant and of interest in the national or international panorama for the field of pharmaceutical assistance, see Table 1. 

Book reviews: this section offers brief summaries of recently published books on various aspects of hospital pharmacy and health services, see Table 1. Each book review should describe the content, objectively, when addressing the following essential points as well as the work's contribution to teaching and research in the field. The relevance, type of information found, gender, style of narrative, ease of reading, illustrations and general format must be pointed out. If possible, compare the work with others published in the same area. The author's background and the type of reader to whom the book is directed should also be briefly described.

Letters to the Editor: letters on hospital pharmacy or health services topics to clarify, discuss or comment constructively on articles published in RBFHSS, see Table 1. The letters must be signed by the author and specify their professional affiliation and address.

The details of formatting, title, authorship, abstract, body text, references, tables, and figures of each type of publication can be found in Table 1.

Table 1. Recommendations for writing and submitting manuscripts to RBFHSS

  1. General criteria for acceptance of the article

The selection of manuscripts for publication is based, above all, on the suitability of the subject for the journal; its scientific rigor, originality, contribution to the advancement of knowledge, and current information. The journal may refuse to publish any manuscript whose authors are unable to answer editorial questions satisfactorily or within the stipulated deadline.

Articles that have been previously published, in print or electronically (e.g., on the Internet), in the same or similar format, should not be submitted and will not be accepted for publication. Any instance of prior publication must be disclosed when the article is submitted, and the authors must provide a copy of the published document.

Manuscripts that do not comply with the submission rules will not be accepted. We recommend that, to make sure they are following the standard RBFHSS format, the authors review all these criteria (checklist available on the website), as well as review one or two articles published in this journal, before submitting their articles for evaluation.

  1. Instructions for article submission

Submission occurs via a platform (www.rbfhss.org.br) in a single file with the .docx or other compatible extension containing all the parts indicated below:

FIRST PAGE

Cover sheet or Title page: it comes with this sequence

Title in English: only the first letter of the title and first names should be capitalized and without an endpoint

Title in Portuguese: only the first letter of the title and first names should be capitalized and without an endpoint

Authors: Name [(Follow: International standards for authors’ names and abbreviations. Example: Maria José Caetano Flores Silva will be abbreviated as Silva MJ, or Flores-Silva MJ or Silva MC, or another possible option (ONE surname, ONE middle name and ONE name). It is recommended that the authors inform the ORCID database registration (https://orcid.org/)], institution and e-mail)

Corresponding author: name and e-mail

Wordcount (except for figures, tables and references):

Abstract wordcount (Portuguese):

Abstract wordcount (English):

Number of tables:

Number of figures:

 

SECOND PAGE ONWARDS

Title in English (first) and title in Portuguese (second): only the first letter of the title and first names should be capitalized. It is recommended that the title be brief and include only the essential data. Ambiguous words, jargon, and abbreviations should be avoided. A good title makes it easy to understand what the manuscript is about and helps to accurately catalog and classify it.

Authorship: inform the full names (ONE name, ONE middle name and ONE surname)

Abstract: see Table 1 to verify structure and limits.

Keywords: 3 to 6 descriptors that will help in the indexation of the articles. See the MESH - Medical Subject Headings: http://www.nlm.nih.gov/mesh/MBrowser.html.

Abstract (in Portuguese): see Table 1 to verify structure and limits.

Keywords (in Portuguese): 3 to 6 descriptors that will help in the indexation of the articles. See http://decs.bvs.br/.

Introduction: if applicable, see Table 1.

Methods: if applicable, see Table 1.

Results: if applicable, see Table 1.

Discussion: if applicable, see Table 1.

Conclusion: if applicable, see Table 1.

Funding sources: Any source of funding or support, both institutional and private, for the studies should be declared. Suppliers of materials and equipment, for free or with discounts, should also be described as financing sources, including the origin (city, state, and country). Provide the approval number and the favored person. In the case of studies carried out without institutional or private financial resources, the authors must declare that the research did not receive funding for its completion.

Collaborators (if more than one author): At the end of the text, the collaboration of the authors (indicating only their name’s initials) in the development of the study and the elaboration of the article should be described, considering the following aspects as criteria of substantial contribution for authors: 1. Project conception or analysis and interpretation of data; 2. Article writing or critical review relevant to the intellectual content. These conditions must be fully met. All the authors must approve the final version to be published and be responsible for all information in the paper, ensuring the accuracy and integrity of any part of it.

Acknowledgments (if any): Possible mentions in the acknowledgments include institutions that somehow made the research possible or people who collaborated with the study but did not meet the co-authorship criteria.

 Declaration of conflict of interests: The authors should disclose any potential conflict of interest, including political or financial interests associated with patents or ownership, provision of materials or inputs and equipment used in the study by the manufacturers. If there is no conflict of interest, inform the following in the article: “The authors declare that there are no conflicts of interest regarding this article.”

References: It is suggested to include the references that are strictly relevant to the problem addressed and to avoid the inclusion of too many references in the same citation. The accuracy of the references is the authors' responsibility. In order to avoid duplicate publications, special emphasis in the search of articles in Hospital Pharmacy journals is recommended. Number the references consecutively according to the order in which they are first mentioned in the text (The NLM Style Guide for Authors, Editors, and Publishers https://www.ncbi.nlm.nih.gov/books/NBK7256/). Identify them in the text with Arabic-superscripted numerals, without mentioning the authors and without parentheses, after the period. When it comes to sequential citation, separate the numbers by a dash (Example: 1-7); when non-sequential, use commas without space (Example: 1,5,7). Only the first three authors should be listed and the others indicated by the term “et al”. The format of the references, using abbreviations according to the Medicus Index, is the following:

Journals: Last name(s), followed by the initials for the first three et al authors. The authors should be separated by a comma. Title of the article. Abbreviated name of the journal. Year;Volume(Issue or number): Number of pages or e-location.

  • Example of a printed journal: Silva LC, Paludetti LA, Cirilo O. Erro de Medicamentos em Hospitais da Grande São Paulo. Rev Bras Farm Hosp Serv Saude. 2003;1(1):303-309.
  • Example of an online journal: Fernandez-Llimos F. Dear author, what is your name? Rev Bras Farm Hosp Serv Saude. 2019 Apr-Jun;10(2):416.

Books: Last name(s), initials of the first three et al authors. Book title, edition. City: publisher; year.

Book Chapter: Last name(s), initials of the first three et al authors. Name of the chapter. “In”: Name of the Editor (ed). Book title, edition. City: publisher, year: pages.

Internet: Author of the page. Title of the page. Available in: full URL address. Accessed on: date.

Abstracts published in journal annals: Last name(s), followed by the initials for the first three et al authors. The authors should be separated by a comma. Title of the abstract. Abbreviated name of the journal. Year;Volume(Issue or number): Number of pages or e-location.

Abstracts published in other media: Last name(s), followed by the initials for the first three et al authors. The authors should be separated by a comma. Title of the abstract. Title and subtitle (if any) of the event. City, month (optional) year. (Optional) page number.

Dissertation, Thesis, and Course Completion Work: Author. Title [Type of document]. Unit where it was defended, City, year.

 

Tables and figures: they must be inserted after the references, one per page, with their titles at the top, numbered consecutively with Arabic numerals, in the order in which they were cited in the text and no horizontal or vertical inside lines shall be used. There are no “charts”, they are presented as Tables. When accepted for publication, the submission of an editable version of the article will be requested, in the .docx, .xls; .pptx or similar extensions, of tables and figures to proceed with the translation.

  • Tables: place on the first line an upper border that is thicker than the lower border and on the last line a lower border of the same thickness as the lower border of the first line. Do not introduce lines in the body of the table.
  • Figures (they include the designs, graphics, and photos, among others). They will be accepted as long as they do not repeat data contained in tables. They must be designed, elaborated or photographed. Figures adapted from other works must have authorization from the original author of the publication. In case photos are used, the subjects cannot be identified. Otherwise, the authors shall attach the permission upon submission, for scientific dissemination purposes. They must be clear enough to allow them to be reproduced in 7.2 cm (width of the text column) or 15 cm (width of the page). For illustrations extracted from previously published papers, the authors must attach a written permission to reproduce them. In the keys to the figures, the symbols, arrows, numbers, letters and other signs shall be identified and their meaning clarified. After acceptance of the article, the files of graphics and figures originated, as well as their databases, must be attached in order to allow for their translation into English and accurate diagramming.

Additional instructions

Abbreviations: Use only standardized and internationally accepted abbreviations, also indicating them unabbreviated in their first mention. In the Tables, non-standardized abbreviations can be used and they must be explained in footnotes using symbols such as *, or #.

Participants’ testimonials: The participants’ testimonials should be presented in between quotation marks in the text. Example: “society is increasingly violent” (subject 1).

Explanatory notes: they must be put only as a footer for tables and charts;

SBRAFH covers the costs of translating the article into English, except for the Title, the Abstract and the supplementary material that must come in Portuguese and in English. The authors are responsible for the review and quality of the translated text.

Doubts: rbfhss@sbrafh.org.br

Privacy Statement

The names and addresses informed in this journal will be used exclusively for the services provided by this publication and are not available for other purposes or to third parties.